Role of macrophage polarization in multi-organ fibrosis of chronic GVHD

Information

  • Research Project
  • 10248556
  • ApplicationId
    10248556
  • Core Project Number
    R01HL151195
  • Full Project Number
    5R01HL151195-02
  • Serial Number
    151195
  • FOA Number
    PA-19-056
  • Sub Project Id
  • Project Start Date
    9/1/2020 - 4 years ago
  • Project End Date
    7/31/2024 - 3 months ago
  • Program Officer Name
    EL KASSAR, NAHED
  • Budget Start Date
    8/1/2021 - 3 years ago
  • Budget End Date
    7/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    9/6/2021 - 3 years ago
Organizations

Role of macrophage polarization in multi-organ fibrosis of chronic GVHD

Project Summary/Abstract Chronic graft versus host disease (cGVHD) represents the leading cause of non-relapse mortality and morbidity after allogeneic hematopoietic stem cell transplantation (HCT). It is typically clinically manifested as an autoimmune-like syndrome and systemic fibrosis. Recent studies have suggested that macrophages with an anti-inflammatory M2-phenotype are capable of promoting fibrosis in cGVHD. However, it remains largely undefined what drives the polarization of M2 macrophages at sites of cGVHD and how M2 macrophages promote GVHD-related fibrotic changes. The objective of this application is to understand the role of hedgehog (Hh) signaling in the polarization of M2 macrophages and systemic fibrosis. Specifically, we will test the hypothesis that the Hh signaling pathway is critical for M2 macrophage polarization in cGVHD target organs, which in turn promotes fibrosis through the production of fibrogenic factors. We will employ mouse models and human tissues to pursue four specific aims that will allow us to define the role of Hh signaling and the source of sonic hedgehog (SHH) in promoting pro-fibrotic macrophages in cGVHD; we will delineate molecular mechanisms and factors mediated by macrophages that lead to an ongoing pro-fibrotic state in GVHD, and end-organ fibrosis in cGVHD. The long-term objective of this project is to define the role of Hh signaling in cGVHD by providing a mechanistic understanding of its effects on macrophage polarization within GVHD target organs and its contributions to immune cell dysregulations and tissue fibrosis. Our work may lead to the development of novel therapeutic strategies for treating systemic fibrosis in cGVHD.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
    356608
  • Indirect Cost Amount
    190516
  • Total Cost
    547124
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    839
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NHLBI:547124\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    CII
  • Study Section Name
    Cancer Immunopathology and Immunotherapy Study Section
  • Organization Name
    OHIO STATE UNIVERSITY
  • Organization Department
    INTERNAL MEDICINE/MEDICINE
  • Organization DUNS
    832127323
  • Organization City
    COLUMBUS
  • Organization State
    OH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    432101016
  • Organization District
    UNITED STATES